Aclaris Therapeutics to Present at the Jefferies Virtual Healthcare Conference

Rhea-AI Summary

WAYNE, Pa., May 26, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics (NASDAQ: ACRS) announced its participation in the Jefferies Virtual Healthcare Conference on June 3, 2020, at 1:00 p.m. ET. The presentation will provide a company overview, which can be accessed via a live audio webcast on Aclaris’ website, with an archived version available for 30 days. Aclaris is dedicated to treating immuno-inflammatory diseases, featuring a diverse portfolio that includes a late-stage drug candidate supported by a strong R&D initiative.

News Market Reaction – ACRS

+1.52%

1 alert

+1.52% News Effect

On the day this news was published, ACRS gained 1.52%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WAYNE, Pa., May 26, 2020 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, today announced that management will present a company overview at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 1:00 p.m. ET.

A live audio webcast of the presentation may be accessed through the Events section of Aclaris’ website, www.aclaristx.com. An archived version of the webcast will be available for 30 days.

About Aclaris Therapeutics, Inc.
Aclaris Therapeutics, Inc. is a physician-led biopharmaceutical company committed to addressing the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company’s diverse and multi-stage portfolio includes one late-stage investigational drug candidate and a pipeline powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com and follow Aclaris on LinkedIn or Twitter @aclaristx.

Aclaris Contact
investors@aclaristx.com

FAQ

What conference will Aclaris Therapeutics attend on June 3, 2020?

Aclaris Therapeutics will present at the Jefferies Virtual Healthcare Conference on June 3, 2020.

What time is Aclaris' presentation at the Jefferies Conference?

The presentation is scheduled for 1:00 p.m. ET.

How can I access Aclaris Therapeutics' presentation?

You can access the live audio webcast through the Events section of Aclaris’ website.

Will there be a recording of Aclaris Therapeutics' presentation available?

Yes, an archived version of the presentation will be available for 30 days.

What is the focus of Aclaris Therapeutics?

Aclaris Therapeutics focuses on addressing immuno-inflammatory diseases with a commitment to patient needs.